Messing and colleagues reported that p.Arg239His GFAP increased Gfap promoter activity in mice compared to WT GFAP [43]. This finding may be extended to other pathogenic GFAP mutations. If this is the case, higher aggregations we observed for pathogenic GFAP mutations might ensue from higher GFAP expression, at least in part. This notion warrants further investigation.